Trademark: 90710106
Word
MEGZURPAZ
Status
Pending
Status Code
731
Status Date
Tuesday, January 2, 2024
Serial Number
90710106
Mark Type
4000
Filing Date
Thursday, May 13, 2021
Published for Opposition
Tuesday, November 8, 2022

Trademark Owner History
Celgene Corporation - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical preparations for human use for immunotherapy, namely, T Cell therapy

Trademark Events
Jan 4, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 2, 2024
Sou Extension 2 Granted
Jan 2, 2024
Sou Extension 2 Filed
Jan 2, 2024
Sou Teas Extension Received
Jun 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 28, 2023
Sou Extension 1 Granted
Jun 28, 2023
Sou Extension 1 Filed
Jun 28, 2023
Sou Teas Extension Received
Jan 3, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 8, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 8, 2022
Published For Opposition
Oct 19, 2022
Notification Of Notice Of Publication E-Mailed
Oct 1, 2022
Approved For Pub - Principal Register
Sep 13, 2022
Teas/Email Correspondence Entered
Sep 13, 2022
Correspondence Received In Law Office
Sep 12, 2022
Assigned To Lie
Aug 9, 2022
Notice Of Revival - E-Mailed
Aug 9, 2022
Teas Response To Office Action Received
Aug 9, 2022
Petition To Revive-Granted
Aug 9, 2022
Teas Petition To Revive Received
Aug 8, 2022
Abandonment Notice E-Mailed - Failure To Respond
Aug 8, 2022
Abandonment - Failure To Respond Or Late Response
Jan 25, 2022
Notification Of Non-Final Action E-Mailed
Jan 25, 2022
Non-Final Action E-Mailed
Jan 25, 2022
Non-Final Action Written
Jan 20, 2022
Assigned To Examiner
Aug 12, 2021
New Application Office Supplied Data Entered
May 17, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24